A notable mover in today’s trading session is FibroGen, Inc (NASDAQ:FGEN) as the stock opened the most recent session at 23.71 and at the time of writing the last Bid was at 23.78. In the current trading session the stock reached as high as 23.89 and dipped down to 23.50. FibroGen, Inc, a NMS listed company, has a current market cap of 1.41B and on average over the past 3 months has seen 739210 shares trade hands on a daily basis.
There are a number of sell-side research firms which offer projections on earnings and future direction of the stock. Wall Street analysts have a consensus short term price of 40.25 on the equity. On a trailing twelve month basis, the company’s earnings per share stands at -2.96. The consensus analyst estimates according to Thomson Reuters First Call for the next quarter is -0.64. The current year EPS estimate on the stock is -1.31 and the EPS estimate for next year sits at -1.46.
On a technical level the stock has a 50 Day Moving Average of 20.79. Based on a recent trade, this puts the equity at +14.39% away from that average. In comparing the stock’s current level to its extended history, the stock is trading -41.41% away from its 52-week high of 40.59 and +40.29% away from the stock’s low point over the past 52 weeks, which was 16.95.
The price to earnings ratio, or the valuation ratio of a company’s current share price compared to its per-share earnings sits at N/A. This is an important indicator as a higher ratio typically suggests that investors are expecting higher future earnings growth compared to companies in the same industry with lower price to earnings ratios. When calculating in the EPS estimates for the current year from sell-side analysts, the Price to current year EPS stands at N/A. Investors looking further ahead, will note that the Price to next year’s EPS is N/A.